|
| PSM之前 | PSM之后 | ||||
|
| 截肢 (n = 67) | 保肢 (n = 323) | P | 截肢 (n = 67) | 保肢 (n = 67) | P |
| 年龄 |
| 0.255 |
|
| 0.221 | |
| <60 | 42 | 178 |
| 42 | 35 |
|
| ≥60 | 25 | 145 |
| 25 | 32 |
|
| 种族 |
|
| 0.275 |
|
| 0.765 |
| 黑人 | 11 | 33 |
| 11 | 10 |
|
| 其他 | 6 | 41 |
| 6 | 4 |
|
| 白人 | 50 | 249 |
| 50 | 53 |
|
| 性别 |
|
| .830 |
|
| 0.600 |
| 女性 | 30 | 140 |
| 30 | 27 |
|
| 男性 | 37 | 183 |
| 37 | 40 |
|
| 原发部位 |
|
| 0.573 |
|
| 0.829 |
| 下肢 | 53 | 265 |
| 53 | 54 |
|
| 上肢 | 14 | 58 |
| 14 | 13 |
|
| 组织学类型 |
|
| 0.648 |
|
| 0.597 |
| 纤维肉瘤 | 7 | 21 |
| 7 | 4 |
|
| 平滑肌肉瘤 | 5 | 34 |
| 5 | 2 |
|
| 脂肪肉瘤 | 3 | 32 |
| 3 | 6 |
|
| 恶性纤维组织细胞瘤 | 5 | 30 |
| 5 | 6 |
|
| 恶性周围神经鞘瘤 | 2 | 9 |
| 2 | 3 |
|
| 其他 | 39 | 167 |
| 39 | 43 |
|
| 滑膜肉瘤 | 6 | 30 |
| 6 | 3 |
|
| 肿瘤等级 |
|
| 0.644 |
|
| 0.334 |
| I | 2 | 8 |
| 2 | 3 |
|
| II | 5 | 40 |
| 5 | 8 |
|
| III | 23 | 95 |
| 23 | 14 |
|
| IV | 37 | 180 |
| 37 | 42 |
|
| T分期 |
|
| 0.280 |
|
| 0.226 |
| T1 | 4 | 33 |
| 4 | 8 |
|
| T2 | 63 | 290 |
| 63 | 59 |
|
| N分期 |
|
| <0.001 |
|
| 0.242 |
| N0 | 46 | 288 |
| 46 | 52 |
|
| N1 | 21 | 35 |
| 21 | 15 |
|
| 肿瘤大小 |
|
| 0.556 |
|
| 0.312 |
| ≤5 cm | 4 | 33 |
| 4 | 8 |
|
| 5.1~10 cm | 22 | 103 |
| 22 | 16 |
|
| >10 cm | 41 | 187 |
| 41 | 43 |
|
| 放射治疗 |
|
| 0.000 |
|
| 0.074 |
| 未做过 | 47 | 141 |
| 47 | 37 |
|
| 做过 | 20 | 182 |
| 20 | 30 |
|
| 化学治疗 |
|
| 0.707 |
|
| 0.226 |
| 未做过 | 28 | 127 |
| 28 | 35 |
|
| 做过 | 39 | 196 |
| 39 | 32 |
|